Large Randomized Trial Finds Proton Therapy Offers No Survival Advantage in Advanced Liver Cancer
The Phase III NRG-GI003 trial was stopped early for futility after proton therapy failed to improve overall survival compared with ...
The Phase III NRG-GI003 trial was stopped early for futility after proton therapy failed to improve overall survival compared with ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine